Sign inGet started

Pauls Dietrich John

Insider CIK 1760123 · DMAC President and CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
DMAC DiaMedica Therapeutics Inc A Award2026-08-102026-08-1260,200— $0128,791SEC↗
DMAC DiaMedica Therapeutics Inc A Award2026-08-102026-08-1260,200— $0128,791SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2026-06-012026-06-03380,000— $0380,000SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2025-06-012025-06-03600,000— $0600,000SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2024-06-012024-06-03300,000— $0300,000SEC↗
DMAC DiaMedica Therapeutics Inc P Buy2023-06-232023-06-2612,787$3.91 $50.0K68,591SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2023-06-012023-06-02181,000— $0181,000SEC↗
DMAX DiaMedica Therapeutics Inc P Buy2022-11-162022-11-1620,000$1.21 $24.2K55,804SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2022-06-012022-06-02177,000— $0177,000SEC↗
DMAC DiaMedica Therapeutics Inc P Buy2021-08-162021-08-165,000$3.14 $15.7K35,804SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2021-07-282021-07-29175,000— $0175,000SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2020-06-012020-06-0256,000— $056,000SEC↗
DMAC DiaMedica Therapeutics Inc P Buy2019-08-162019-08-161,000$2.68 $2.7K30,804SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2019-06-242019-06-26264,000— $0264,000SEC↗
DMAC DiaMedica Therapeutics Inc P Buy2018-12-112018-12-115,000$4.00 $20.0K29,804SEC↗